ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Gynaecological Malignancies
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
SOLO2 Final Analysis Demonstrates ‘Unprecedented’ OS Boost
New Standard Regimen Proposed For Recurrent Ovarian Cancer
Phase Ib/II Lenvatinib–Pembrolizumab Trial Indicates Potential Against Solid Tumours
OS Remains Best Endpoint For Ovarian Cancer Trials
Ipilimumab ‘Feasible’ Option For Locally Advanced Cervical Cancer
E-Learning
ESMO E-Learning: HPV-Related Cancers: Prevention, Vaccines and Treatment
ESMO E-Learning: Ovarian Cancer IP Chemotherapy
ESMO E-Learning: Management of BRCA Mutated Ovarian Cancer
ESMO E-Learning: Targeting Angiogenesis in Ovarian Cancer
Factsheets on Biomarkers
Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
BRCA1 and BRCA2 in Ovarian Cancer: ESMO Biomarker Factsheet
Meeting resources
Gynaecological malignancies
Presenter: C. Sessa, CH
Session: Session 3 - Clinical development
Resources:
Slides
Webcast
93P - CXCL8 and CCL2 production in circulating neutrophils in endometrial cancer
Presenter: Tatyana Abakumova
Session: e-Poster Display Session
Resources:
Abstract
76P - Highly potent fully human anti-VISTA antibodies efficiently abrogate the interaction of this new target checkpoint inhibitor to its different putative receptors at different pH
Presenter: Thierry Guillaudeux
Session: e-Poster Display Session
Resources:
Abstract
57P - The efficacy and safety of pembrolizumab in advanced cervical cancer: A real-world treatment study
Presenter: Iseult Browne
Session: e-Poster Display Session
Resources:
Abstract
2P - Lung immune prognostic index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours
Presenter: Edouard Auclin
Session: e-Poster Display Session
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.